Position in MYGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,202,975
-$2,027,754 QoQ
Shares Held
267,328
-49.1% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $3,113,771,208 across 32 Diagnostics & Research names. MYGN ranks #27 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,670,400 | $821,051,708 | |
| 2 | DHR |
Danaher Corp /De/
|
3,041,408 | $576,650,954 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
1,624,321 | $277,011,701 | |
| 4 | WAT |
Waters Corp /De/
|
695,644 | $207,162,780 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
1,109,387 | $191,369,256 | |
| 6 | DGX |
Quest Diagnostics Inc
|
807,477 | $158,249,338 | |
| 7 | ILMN |
Illumina, Inc.
|
1,155,973 | $142,485,227 | |
| 8 | A |
Agilent Technologies, Inc.
|
1,204,289 | $137,264,856 |
All Filings in MYGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,202,975 | 267,328 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,230,729 | 525,322 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,926,410 | 543,072 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,211,307 | 416,442 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,761,989 | 198,646 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,877,934 | 209,915 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,349,522 | 231,819 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,198,603 | 253,418 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,606,242 | 262,957 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,186,250 | 270,964 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,332,419 | 270,101 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,888,006 | 297,153 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,222,044 | 310,893 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $4,623,494 | 318,642 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,160,822 | 480,127 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,759,299 | 702,218 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $18,154,734 | 720,426 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $19,730,246 | 714,864 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $21,119,887 | 654,069 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,633,583 | 347,730 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $10,556,070 | 346,669 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $6,483,966 | 327,970 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,849,638 | 448,592 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,196,536 | 370,065 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $5,338,387 | 373,053 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||